Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study-Reference-Cited by-同舟云学术

Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study

Published:2013-02-13 Issue:2 Volume:28 Page:219-225
ISSN:0267-8357
Container-title:Mutagenesis
language:en
Short-container-title:Mutagenesis

Author:

Rangel-Lopez A.,Paniagua-Medina M. E.,Urban-Reyes M.,Cortes-Arredondo M.,Alvarez-Aguilar C.,Lopez-Meza J.,Ochoa-Zarzosa A.,Lindholm B.,Garcia-Lopez E.,Paniagua J. R.

Publisher

Oxford University Press (OUP)

Subject

Health, Toxicology and Mutagenesis,Genetics (clinical),Toxicology,Genetics

Link

http://academic.oup.com/mutage/article-pdf/28/2/219/12755403/ges075.pdf

Reference59 articles.

1. Causes and Consequences of Chronic Kidney Disease: Implications for Managed Health Care

2. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study

3. Genomic Damage and Malignancy in End-Stage Renal Failure: Do Advanced Glycation End Products Contribute?

4. Effect of Different Hemodialysis Regimens on Genomic Damage in End-Stage Renal Failure

5. Increased genomic damage in lymphocytes of patients before and after long-term maintenance hemodialysis therapy

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baseline and oxidatively damaged DNA in end-stage renal disease patients on varied hemodialysis regimens: a comet assay assessment;MOL CELL BIOCHEM;2024

2. The relationship between lymphocyte DNA damage, coronary artery disease, and blood trace elements;Mutagenesis;2023-10-11

3. Chapter 4: CKD treatment in cancer survivors, from Clinical Practice Guidelines for the Management of Kidney Injury During Anticancer Drug Therapy 2022;International Journal of Clinical Oncology;2023-07-07

4. Investigation of XPD, miR-145 and miR-770 expression in patients with end-stage renal disease;Molecular Biology Reports;2023-07-01

5. Investigation of XPD, miR-145 and miR-770 expression in patients with end-stage renal disease;2023-04-14